醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
LYEL · Lyell Immunopharma, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Lyell Immunopharma, Inc.（LYEL）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $215K；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-13。
買入 Bought—
賣出 Sold$215K
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-12 | Aguirre Jarrad Mattieu Chief Medical Officer | 賣出 Sell | 422 | $8.63 | $4K | SEC |
| 2026-09-10 | Shook David Chief Medical Officer | 賣出 Sell | 500 | $12.70 | $6K | SEC |
| 2026-08-21 | Hill Stephen J. Chief Operating Officer | 賣出 Sell | 989 | $15.54 | $15K | SEC |
| 2026-08-21 | Lee Gary K. Chief Scientific Officer | 賣出 Sell | 1,457 | $15.54 | $23K | SEC |
| 2026-08-21 | Seely Lynn Director, President and CEO | 賣出 Sell | 9,589 | $15.54 | $149K | SEC |
| 2026-08-10 | Bulis Veronica Sanchez VP, Corporate Controller | 賣出 Sell | 621 | $14.34 | $9K | SEC |
| 2026-08-10 | Hill Stephen J. Chief Operating Officer | 賣出 Sell | 89 | $14.34 | $1K | SEC |
| 2026-08-10 | Lee Gary K. Chief Scientific Officer | 賣出 Sell | 131 | $14.34 | $2K | SEC |
| 2026-08-10 | Seely Lynn Director, President and CEO | 賣出 Sell | 390 | $14.34 | $6K | SEC |
| 2026-07-17 | Innovative Cellular Therapeutics Holdings Ltd 10% Owner | 賣出 Sell | 10 | $13.70 | $137 | SEC |
| 2026-07-16 | Innovative Cellular Therapeutics Holdings Ltd 10% Owner | 賣出 Sell | 10 | $13.70 | $137 | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
內部人 Insiders
Aguirre Jarrad Mattieu、Shook David、Hill Stephen J.、Lee Gary K.、Seely Lynn、Bulis Veronica Sanchez、Innovative Cellular Therapeutics Holdings Ltd